Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2016 | 08-2016 | 05-2016 | 02-2016 | 11-2015 | |
| Sales | 610 | 0 | 163 | 125 | 0 |
| Cost of Goods | 187 | N/A | 8 | 4 | N/A |
| Gross Profit | 423 | N/A | 155 | 121 | N/A |
| Operating Expenses | 3,008 | 0 | 2,273 | 2,037 | 2,449 |
| Operating Income | -2,398 | N/A | -2,110 | -1,912 | -2,449 |
| Interest Expense | 24 | 0 | 23 | 34 | 17 |
| Other Income | 186 | 0 | 137 | 128 | 76 |
| Pre-tax Income | -2,236 | 0 | -1,996 | -1,818 | -2,390 |
| Income Tax | 400 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -2,636 | N/A | -1,996 | -1,818 | -2,390 |
| Net Income | $-2,636 | $N/A | $-1,996 | $-1,818 | $-2,390 |
| EPS Basic Total Ops | -0.20 | N/A | -0.15 | -0.14 | -0.21 |
| EPS Basic Continuous Ops | -0.20 | N/A | -0.15 | -0.14 | -0.21 |
| EPS Diluted Total Ops | -0.20 | N/A | -0.15 | -0.14 | -0.21 |
| EPS Diluted Continuous Ops | -0.20 | N/A | -0.15 | -0.14 | -0.21 |
| EBITDA(a) | $-2,396 | $N/A | $-2,109 | $-1,910 | $-2,448 |